...
首页> 外文期刊>Biochemical Pharmacology >Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
【24h】

Strategies for the identification of allosteric modulators of G-protein-coupled receptors.

机译:鉴定G蛋白偶联受体的变构调节剂的策略。

获取原文
获取原文并翻译 | 示例

摘要

Once considered a pharmacological curiosity, allosteric modulation of seven transmembrane domain G-protein-coupled receptors (GPCRs) has emerged as a potentially powerful means to affect receptor function for therapeutic purposes. Allosteric modulators, which interact with binding sites topologically distinct from the orthosteric ligand binding sites, can potentially provide improved selectivity and safety, along with maintenance of spatial and temporal aspects of GPCR signaling. Accordingly, drug discovery efforts for GPCRs have increasingly focused on the identification of allosteric modulators. This review is devoted to an examination of the strategies, challenges, and opportunities for high-throughput screening for allosteric modulators of GPCRs, with particular focus on the identification of positive allosteric modulators.
机译:一旦被视为具有药理学的好奇心,七个跨膜域G蛋白偶联受体(GPCR)的变构调节已成为影响治疗目的受体功能的潜在强大手段。与拓扑学上不同于正构配体结合位点的结合位点相互作用的变构调节剂可以潜在地提供改进的选择性和安全性,以及维持GPCR信号传导的时空方面。因此,用于GPCR的药物发现努力已越来越集中于变构调节剂的鉴定。这篇综述专门针对高通量筛选GPCR的变构调节剂的策略,挑战和机会进行了检查,尤其侧重于阳性变构调节剂的鉴定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号